Yoon notes the following as attractive invesment opportunities:
– Biotech drug innovation
– Global demographic trends
– Effective capital allocation
– New IT enhancements
– Pharmacueticals
– Medical Equipment Stocks
Some risks Yoon notes on these investments are the uncertainity surrounding U.S. health care reform and drug pricing and reimbursement pressure.
To read the report in full, click here.
To learn more about Fidelity Investments, click here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
